PRODUCT COMMERCIALIZATION AGREEMENTProduct Commercialization Agreement • November 2nd, 2009 • Valeant Pharmaceuticals International • Pharmaceutical preparations
This Product Commercialization Agreement (this “Agreement”) is entered into by and between Mylan Pharmaceuticals Inc. (“Mylan”), a West Virginia corporation having its corporate offices at 781 Chestnut Ridge, Morgantown, West Virginia, 26505 and Dow Pharmaceutical Sciences, Inc. (“DPSI”), a Delaware corporation having its corporate offices at 1330 Redwood Way, Petaluma, California, 94954-1169.
